CardieX rises after seeking FDA nod for blood pressure monitor

Conneqt Health

28/06/2022 02:24

** Shares of the Australian medical device maker  CDX.AX 
jump as much as 15.5% to A$0.335, their highest since June 22
    ** Co says it has submitted its U.S. FDA clearance
application for its "pulse" dual blood pressure and arterial
health monitor  urn:newsml:reuters.com:*:nASXWXjH4
    ** Stock down 58% this year, as of last close, vs a 9.7%
fall in the benchmark S&P/ASX 200 index  .AXJO  

 (Reporting by Roushni Nair in Bengaluru)
 ((Roushni.Nair@thomsonreuters.com;))